Molecules to Medicine
The s**t hits the fan – FDA, INDs, and fecal microbiota transplants
May 20th, 2013 |
6
This weekend, the proverbial s**t hit the fan over the Food & Drug Administration’s (FDA) decision to require an Investigational New Drug (IND) application for stool transplants—formally known as “fecal microbiota transplants (FMT)”—for the treatment of C. difficile colitis. “C. diff,” as it is known, is a severe inflammation of the bowel complicating treatment of [...]
Keep reading »
See what we're tweeting about
